Kaytlyn Gerbin, Ph.D.
Kaytlyn Gerbin joined the Stem Cell and Gene Editing Team in 2017 as a hiPSC Differentiation Scientist/Bioengineer. Her current work focuses on implementing cardiac differentiation methods and developing the cardiomyocyte pipeline using the gene-edited human induced pluripotent stem cells (hiPSCs) produced within the group. Kaytlyn obtained her PhD in Bioengineering at the University of Washington, where she studied cell transplantation and tissue engineering for cardiac regenerative medicine, using stem cell-derived cardiomyocytes in Chuck Murry’s lab. Prior to her graduate work, she completed her Bachelor’s of Science in Mathematics at the University of Wisconsin.
May 27, 2020
Gerbin KA, Grancharova T, Donovan-Maiye R, Hendershott MC, Brown J, Dinh SQ, Gehring JL, Hirano M, Johnson GR, Nath A, Nelson A, Roco CM, Rosenberg AB, Sluzewski MF, Viana MP, Yan C, Zaunbrecher RJ, Cordes Metzler KR, Menon V, Palecek SP, Seelig G, Gaudreault N, Knijnenburg T, Rafelski SM, Theriot JA, Gunawardane RN
Stem Cell Reports
April 4, 2019
Roberts B, Hendershott MC, Arakaki J, Gerbin KA, Malik H, Nelson A, Gehring J, Hookway C, Ludmann SA, Yang R, Haupt A, Grancharova T, Valencia V, Fuqua MA, Tucker A, Rafelski SM, Gunawardane RN
June 9, 2018
Roberts B, Arakaki J, Gerbin KA, Malik H, Nelson A, Hendershott MC, Hookway C, Ludmann SA, Mueller IA, Yang R, Rafelski SM, Gunawardane RN